Featured News
AIM Blog
A Promising Moment, an Urgent Challenge: The Latest Data Strengthens the Case for the ASAP Act
There has never been a more promising moment in Alzheimer’s and dementia research. Scientists have developed blood tests capable of detecting Alzheimer’s biomarkers earlier and more accurately than ev...
All News
Press Release
Alzheimer’s Association Statement on First Blood Test Used in Diagnosing Alzheimer’s Disease Cleared for Use by FDA
CHICAGO, May 16, 2025 — The U.S. Food and Drug Administration (FDA) has cleared the first blood test to aid...
Press Release
Contrary to Clear, Verifiable Facts, Secretary Kennedy Continues to Repeat Harmful Myths About Alzheimer’s and Dementia Research
Washington, D.C., May 15, 2025 — During two congressional budget hearings held yesterday, Department of Health and Human Services (HHS)...
Press Release
Alzheimer’s Association and Alzheimer’s Impact Movement Statement on Proposed Changes to Medicaid
CHICAGO, May 12, 2025 — On behalf of Americans impacted by dementia, the Alzheimer’s Association is concerned with some of...
AIM Blog
Recognizing AIM’s May Advocate of the Month: Mike Hickman
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted...
Press Release
Alzheimer’s Association Statement on Trump Administration Proposed FY26 Budget
CHICAGO, May 2, 2025 — On behalf of the more than 7 million Americans currently living with Alzheimer’s and the...
Press Release
Strong Bipartisan Support for Continued Investment in Alzheimer’s Research on Full Display During Senate Appropriations Hearing
Senate appropriators from both sides of the aisle raise warnings of harm that would come from proposed research funding and...